Mutant Prevention Concentrations of ABT-492, Levofloxacin, Moxifloxacin, and Gatifloxacin against Three Common Respiratory Pathogens
Open Access
- 1 April 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (4), 1633-1635
- https://doi.org/10.1128/aac.49.4.1633-1635.2005
Abstract
The purpose of this study was to compare the mutant prevention concentration (MPC) of ABT-492 to those of levofloxacin, moxifloxacin, and gatifloxacin against Streptococcus pneumoniae , Haemophilus influenzae , and Moraxella catarrhalis . The fluoroquinolones had comparable mutation selection windows, which is the ratio of MPC/MIC, for all isolates.Keywords
This publication has 14 references indexed in Scilit:
- Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 2003
- Stretching the mutant prevention concentration (MPC) beyond its limitsJournal of Antimicrobial Chemotherapy, 2003
- Mutant Prevention Concentration of Garenoxacin (BMS-284756) for Ciprofloxacin-Susceptible or -Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Restricting the Selection of Antibiotic‐Resistant Mutant Bacteria: Measurement and Potential Use of the Mutant Selection WindowThe Journal of Infectious Diseases, 2002
- Restricting the Selection of Antibiotic‐Resistant Mutants: A General Strategy Derived from Fluoroquinolone StudiesClinical Infectious Diseases, 2001
- Antimicrobial resistance mechanisms: What's hot and what's not in respiratory pathogens☆Seminars in Respiratory Infections, 2001
- Emerging Mechanisms of Fluoroquinolone ResistanceEmerging Infectious Diseases, 2001
- Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Mutant Prevention Concentration as a Measure of Antibiotic Potency: Studies with Clinical Isolates of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2000
- Effect of Fluoroquinolone Concentration on Selection of Resistant Mutants of Mycobacterium bovis BCG and Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1999